4.4 Article

Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance

Ala M. Shaqra et al.

Summary: The study determined the crystal structures of SARS-CoV-2 main protease (Mpro) bound to substrate peptides, defining the substrate envelope and identifying sites susceptible to drug resistance. These findings provide insights for developing robust inhibitors against SARS-CoV-2 and preventing drug resistance.

NATURE COMMUNICATIONS (2022)

Article Biology

Comprehensive fitness landscape of SARS-CoV-2 M-pro reveals insights into viral resistance mechanisms

Julia M. Flynn et al.

Summary: The evolution of pathogens necessitates effective antiviral drugs, with drug design targeting the SARS-CoV-2 main protease (M-pro) showing promise and progress in identifying mutation sites resistant to drugs.

ELIFE (2022)

Editorial Material Multidisciplinary Sciences

A white-knuckle ride of open COVID drug discovery

Frank von Delft et al.

NATURE (2021)

Article Biochemistry & Molecular Biology

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor

Daniel Zaidman et al.

Summary: The computational pipeline presented in this study identifies irreversible inhibitors that can bind covalently to cysteine, showing promise for drug development in recent prospective evaluations.

CELL CHEMICAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function

Mai Luo et al.

Summary: This study found that the natural product nimbolide can be used as a recruiter of the E3 ubiquitin ligase RNF114 for targeted protein degradation, which is important in modern drug discovery. Through activity-based protein profiling-enabled ligand screening, fully synthetic molecules mimicking nimbolide were discovered, showing potential for degrading therapeutic targets.

CELL CHEMICAL BIOLOGY (2021)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Review Biochemistry & Molecular Biology

Covalent inhibitors: a rational approach to drug discovery

Fandi Sutanto et al.

RSC MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Carl C. Ward et al.

ACS CHEMICAL BIOLOGY (2019)